PMA P030052S005

Device
UROVYSION BLADDER CANCER KIT
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S005
Product code
NSD
Decision date
2011-04-08
Classification
Test, Fluorescence In Situ Hybridization (fish), For Bladder Cancer Detection And Monitoring For Recurrence
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Approval order statement
CHANGES TO THE REFERENCE DNA MANUFACTURING AND THE SMALL SCALE FERMENTATION PROCESSES.

Current openFDA PMA Record#

Device
UROVYSION BLADDER CANCER KIT
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S005
Product code
NSD
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Decision date
2011-04-08
Decision code
OK30
Date received
2011-03-18
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
CHANGES TO THE REFERENCE DNA MANUFACTURING AND THE SMALL SCALE FERMENTATION PROCESSES.